Stay updated on Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial
Sign up to get notified when there's something new on the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page.

Latest updates to the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page
- Check4 days agoNo Change Detected
- Check12 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2, indicating a revision in the content.SummaryDifference0.1%
- Check19 days agoNo Change Detected
- Check26 days agoChange DetectedThe page has undergone significant content removal, including the deletion of a detailed study description and inclusion/exclusion criteria for a clinical trial on anti-PD-1 therapy for malignant mesothelioma. The only notable addition is a revision number update.SummaryDifference31%
- Check34 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.1%
- Check77 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check91 days agoChange DetectedThe page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact for assistance.SummaryDifference2%
- Check99 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
Stay in the know with updates to Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Immunotherapy & Hyperthermia in Mesothelioma Clinical Trial page.